C12N 2760/18132
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2760/18132 (Use of virus as therapeutic agent, other than vaccine) appears on 26 US grants and 63 published applications in this corpus.
Search patents in C12N- Granted patents
- 26
- Published applications
- 63
- Assignees
- 23
- Inventors
- 86
- Latest grant
- 23 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 1 |
| 2005 | 0 | 3 |
| 2006 | 2 | 5 |
| 2007 | 1 | 3 |
| 2008 | 0 | 3 |
| 2009 | 2 | 4 |
| 2010 | 3 | 3 |
| 2011 | 1 | 3 |
| 2012 | 2 | 1 |
| 2013 | 2 | 1 |
| 2014 | 0 | 4 |
| 2015 | 2 | 0 |
| 2016 | 0 | 4 |
| 2017 | 1 | 1 |
| 2018 | 2 | 3 |
| 2019 | 2 | 2 |
| 2020 | 0 | 3 |
| 2021 | 0 | 1 |
| 2022 | 3 | 6 |
| 2023 | 0 | 5 |
| 2024 | 2 | 2 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Newcastle disease viruses and uses thereof23 Jul 2024US 12,042,534 B2Icahn School of Medicine at Mount Sinai
- Oncolytic virus for colorectal cancer treatment using colorectal cancer cell-specific infectious newcastle disease virus and composition for colorectal cancer treatment using same30 Jan 2024US 11,884,931 B2Libentech Co., Ltd.
- Oncolytic virus for treating brain tumors using recombinant Newcastle disease virus into which Newcastle disease virus vector-based PTEN gene is inserted and composition for treating brain tumors using same20 Dec 2022US 11,530,422 B2Libentech Co., Ltd.
- Compositions featuring an attenuated newcastle disease virus and methods of use for treating neoplasia18 Oct 2022US 11,471,499 B2MedImmune, LLC
- Enveloped virus resistant to complement inactivation for the treatment of cancer15 Mar 2022US 11,274,141 B2Wellstat ImmunoTherapeutics, LLC
- Apmv and uses thereof for the treatment of cancer30 Jul 2026US 2026/0216266 A1Icahn School of Medicine at Mount Sinai
- Newcastle disease viruses and uses thereof24 Apr 2025US 2025/0127879 A1Icahn School of Medicine at Mount Sinai
- Recombinant newcastle disease virus and preparation method therefor, recombinant plasmid, and use thereof15 Aug 2024US 2024/0271106 A1Jiangsu Kanionreal Biomedical Technology Co., Ltd
- Recombinant newcastle disease virus rndv-vegf-trap, genome thereof, preparation method therefor, and use thereof18 Apr 2024US 2024/0124852 A1Jiangsu Kanionreal Biomedical Technology Co., Ltd
- Recombinant newcastle disease virus and preparation method therefor, recombinant plasmid, and use thereof29 Jun 2023US 2023/0203454 A1Jiangsu Kanionreal Biomedical Technology Co., Ltd
Most cited
By later US patents
- Treatment of neoplasms with viruses31US 8,105,578 B2Wellstat Biologics Corporation · 2012
- Methods of treating and detecting cancer using viruses17US 7,056,689 B1Wellstat Biologics Corporation · 2006
- Method for treating viral diseases with attenuated virus13US 5,124,148 AUnited Cancer Research Institute · 1992
- Infection and treatment of neoplasms with vesicular stomatitis virus13US 8,043,612 B2Wellstat Biologics Corporation · 2011
- Chimeric Newcastle disease viruses and uses thereof10US 8,591,881 B2Memorial Sloan Kettering Cancer Center · 2013